Clinical study of epidermal growth factor receptor inhibitors
10.3760/cma.j.issn.1008-6706.2017.21.038
- VernacularTitle:表皮生长因子受体抑制剂临床研究
- Author:
Yaqing LYU
1
;
Huichun LYU
Author Information
1. 曲靖市第一人民医院药学部
- Keywords:
Epidermal growth factor receptor inhibitor;
Clinical research;
Overview
- From:
Chinese Journal of Primary Medicine and Pharmacy
2017;24(21):3346-3348
- CountryChina
- Language:Chinese
-
Abstract:
In order to understand the clinical research progress of epidermal growth factor receptor inhibitors,the author reviewed the related research and literature report.It considers that cetuximab is mainly used for colorectal cancer without KRAS gene mutations,and trastuzumab is mainly used for breast cancer and gastric cancer with over expression of HER-2,and gefitinib and icotinib is mainly used for non-small cell lung adenocarcinoma with EGFR gene mutations.The above points of view can provide reference for the clinical application of these drugs.
